BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38485425)

  • 21. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study.
    Watson OJ; Barnsley G; Toor J; Hogan AB; Winskill P; Ghani AC
    Lancet Infect Dis; 2022 Sep; 22(9):1293-1302. PubMed ID: 35753318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study.
    Jit M; Brisson M; Portnoy A; Hutubessy R
    Lancet Glob Health; 2014 Jul; 2(7):e406-14. PubMed ID: 25103394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling the impact of vaccination for the immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030.
    Carter A; Msemburi W; Sim SY; Gaythorpe KAM; Lambach P; Lindstrand A; Hutubessy R
    Vaccine; 2023 Aug; ():. PubMed ID: 37537094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Brisson M; Kim JJ; Canfell K; Drolet M; Gingras G; Burger EA; Martin D; Simms KT; Bénard É; Boily MC; Sy S; Regan C; Keane A; Caruana M; Nguyen DTN; Smith MA; Laprise JF; Jit M; Alary M; Bray F; Fidarova E; Elsheikh F; Bloem PJN; Broutet N; Hutubessy R
    Lancet; 2020 Feb; 395(10224):575-590. PubMed ID: 32007141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunisation coverage and factors associated with incomplete immunisation in children under two during the COVID-19 pandemic in Sierra Leone.
    Wassenaar M; Fombah AE; Chen H; Owusu-Kyei K; Williams J; Sunders JC; Llach M; Quinto L; Sesay T; Samai M; Menéndez C; González R
    BMC Public Health; 2024 Jan; 24(1):143. PubMed ID: 38200476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries.
    Fu H; Abbas K; Klepac P; van Zandvoort K; Tanvir H; Portnoy A; Jit M
    BMC Med; 2021 Nov; 19(1):281. PubMed ID: 34784922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators.
    Spayne J; Hesketh T
    BMJ Open; 2021 Sep; 11(9):e052016. PubMed ID: 34475188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study.
    Simms KT; Hanley SJB; Smith MA; Keane A; Canfell K
    Lancet Public Health; 2020 Apr; 5(4):e223-e234. PubMed ID: 32057317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating national-level measles case-fatality ratios in low-income and middle-income countries: an updated systematic review and modelling study.
    Sbarra AN; Mosser JF; Jit M; Ferrari M; Ramshaw RE; O'Connor P; Krause LK; Rogowski ELB; Portnoy A
    Lancet Glob Health; 2023 Apr; 11(4):e516-e524. PubMed ID: 36925172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study.
    Man I; Georges D; de Carvalho TM; Ray Saraswati L; Bhandari P; Kataria I; Siddiqui M; Muwonge R; Lucas E; Berkhof J; Sankaranarayanan R; Bogaards JA; Basu P; Baussano I
    Lancet Oncol; 2022 Nov; 23(11):1419-1429. PubMed ID: 36174583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How can the public health impact of vaccination be estimated?
    Echeverria-Londono S; Li X; Toor J; de Villiers MJ; Nayagam S; Hallett TB; Abbas K; Jit M; Klepac P; Jean K; Garske T; Ferguson NM; Gaythorpe KAM
    BMC Public Health; 2021 Nov; 21(1):2049. PubMed ID: 34753437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004407. PubMed ID: 32309885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004407. PubMed ID: 34806766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Annual immunisation coverage report 2021.
    Hull B; Hendry A; Dey A; Brotherton J; Macartney K; Beard F
    Commun Dis Intell (2018); 2023 Aug; 47():. PubMed ID: 37817316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of a vaccine recovery plan after the COVID-19 pandemic in the Siracusa Local Health Authority, Italy. Results of one year follow-up.
    Contarino F; DI Pietro E; Randazzo C; Bella F; Contrino ML
    J Prev Med Hyg; 2023 Sep; 64(3):E289-E297. PubMed ID: 38125998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the subnational inequality and heterogeneity of the impact of routine measles immunisation in Africa.
    Echeverria-Londono S; Hartner AM; Li X; Roth J; Portnoy A; Sbarra AN; Abbas K; Ferrari M; Fu H; Jit M; Ferguson NM; Gaythorpe KAM
    Vaccine; 2022 Nov; 40(47):6806-6817. PubMed ID: 36244882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trend of measles-rubella vaccination coverage and impact on measles epidemiology in the Savannah Region, Ghana; 2018-2022: A secondary data analysis.
    Rockson Adjei M; Longsignikuu A; Saeed Iddris I; Nang Suuri T; Asamoah B; Okoye M; Vanessa Baafi J; Kubio C; Ohene SA; Grobusch MP
    Vaccine; 2024 Mar; 42(8):1910-1917. PubMed ID: 38365480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis.
    Prem K; Choi YH; Bénard É; Burger EA; Hadley L; Laprise JF; Regan MC; Drolet M; Sy S; Abbas K; Portnoy A; Kim JJ; Brisson M; Jit M
    BMC Med; 2023 Aug; 21(1):313. PubMed ID: 37635227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Annual Immunisation Coverage Report 2017.
    Hull B; Hendry A; Dey A; Brotherton J; Macartney K; Beard F
    Commun Dis Intell (2018); 2019 Nov; 43():. PubMed ID: 31738865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of COVID-19 and catch-up strategies on routine childhood vaccine coverage trends in Latin America: A systematic literature review and database analysis.
    Castrejon MM; Leal I; de Jesus Pereira Pinto T; Guzmán-Holst A
    Hum Vaccin Immunother; 2022 Nov; 18(6):2102353. PubMed ID: 36084255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.